Connection
Francisco La Rosa to Protein Kinase Inhibitors
This is a "connection" page, showing publications Francisco La Rosa has written about Protein Kinase Inhibitors.
|
|
Connection Strength |
|
 |
|
 |
|
0.067 |
|
|
|
-
Breaker K, Naam M, La Rosa FG, Flaig IP, Flaig TW. Skin cancer associated with the use of sorafenib and sunitinib for renal cell carcinoma. Dermatol Surg. 2013 Jul; 39(7):981-7.
Score: 0.067